While RET fusions are detected in other cancers, such as breast cancer and salivary gland carcinomas (discussed later), RET fusions occur in these cancer types at much lower frequencies (0.16% and 3.2%, respectively) (41). This evidence concerns the gene RET and salivary gland carcinoma.